• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伏立康唑在氟康唑治疗失败后,对一名慢性肾病的HIV阴性患者的脑隐球菌瘤进行长期治疗时被证明有效。

Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.

作者信息

Sabbatani S, Manfredi R, Pavoni M, Consales A, Chiodo F

机构信息

Department of Clinical and Experimental Medicine, Division of Infectious Diseases, University of Bologna Alma Mater Studiorum, S. Orsola Hospital, Bologna, Italy.

出版信息

Mycopathologia. 2004 Aug;158(2):165-71. doi: 10.1023/b:myco.0000041904.71381.e3.

DOI:10.1023/b:myco.0000041904.71381.e3
PMID:15518344
Abstract

Although being a rare occurrence, brain cryptococcoma may represent an emerging issue, because of its relationship with a broadening range of risk factors, including malignancies, neutropenia, end-organ failure, bone marrow and solid-organ transplantation, and multiple underlying causes of primary-secondary immunodeficiency. A cerebral cryptococcoma in a chronic nephropathic HIV-negative subject with homocystinuria, completely cured with neurosurgery and voriconazole after fluconazole failure, is described.

摘要

尽管脑隐球菌瘤较为罕见,但由于其与越来越多的风险因素相关,包括恶性肿瘤、中性粒细胞减少、终末器官衰竭、骨髓和实体器官移植以及原发性-继发性免疫缺陷的多种潜在病因,它可能成为一个新出现的问题。本文描述了一名患有同型胱氨酸尿症的慢性肾病HIV阴性患者发生的脑隐球菌瘤,在氟康唑治疗失败后,通过神经外科手术和伏立康唑完全治愈。

相似文献

1
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.伏立康唑在氟康唑治疗失败后,对一名慢性肾病的HIV阴性患者的脑隐球菌瘤进行长期治疗时被证明有效。
Mycopathologia. 2004 Aug;158(2):165-71. doi: 10.1023/b:myco.0000041904.71381.e3.
2
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.艾滋病相关隐球菌病氟康唑维持治疗期间唑类耐药性的产生
AIDS. 2001 Nov 23;15(17):2344-5. doi: 10.1097/00002030-200111230-00026.
3
New guinea pig model of Cryptococcal meningitis.新型隐球菌性脑膜炎豚鼠模型
Antimicrob Agents Chemother. 2007 Aug;51(8):3011-3. doi: 10.1128/AAC.00085-07. Epub 2007 Jun 11.
4
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].[与HIV感染相关的新型隐球菌性脑膜脑炎,对氟康唑耐药、复发及免疫重建炎症综合征]
Med Klin (Munich). 2009 Jan 15;104(1):58-62. doi: 10.1007/s00063-009-1007-9. Epub 2009 Jan 14.
5
A case of fluconazole, voriconazole-resistant Cryptococcus neoformans isolated from and immunocompetent patient.从一名免疫功能正常患者体内分离出的对氟康唑、伏立康唑耐药的新型隐球菌病例。
J Chemother. 2011 Dec;23(6):379-80. doi: 10.1179/joc.2011.23.6.379.
6
Cryptococcus neoformans var neoformans resistant to fluconazole in an HIV-negative patient with chronic lymphocytic leukemia.一名患有慢性淋巴细胞白血病的HIV阴性患者中出现对氟康唑耐药的新型隐球菌新型变种。
Clin Microbiol Infect. 2003 May;9(5):441-4. doi: 10.1046/j.1469-0691.2003.00571.x.
7
Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis.伏立康唑抑制氟康唑耐药性隐球菌性脑膜炎肾移植受者他克莫司的代谢。
Int J Infect Dis. 2010 Apr;14(4):e348-50. doi: 10.1016/j.ijid.2009.04.012. Epub 2009 Aug 7.
8
Voriconazole: a novel treatment option for cryptococcal meningitis.伏立康唑:治疗隐球菌性脑膜炎的新选择。
Infect Dis (Lond). 2015;47(10):694-700. doi: 10.3109/23744235.2015.1044260. Epub 2015 Jun 23.
9
Treatment of murine cryptococcal meningitis with UR-9751 and UR-9746.用UR-9751和UR-9746治疗小鼠隐球菌性脑膜炎。
Med Mycol. 2000 Jun;38(3):221-4. doi: 10.1080/mmy.38.3.221.224.
10
In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans.新型三唑类药物阿巴康唑对新型隐球菌的体内外疗效
Antimicrob Agents Chemother. 2004 Feb;48(2):384-7. doi: 10.1128/AAC.48.2.384-387.2004.

引用本文的文献

1
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.全球隐球菌病诊断和管理指南:欧洲癌症研究与治疗组织和国际系统性真菌感染学会与美国微生物学会合作开展的一项倡议。
Lancet Infect Dis. 2024 Aug;24(8):e495-e512. doi: 10.1016/S1473-3099(23)00731-4. Epub 2024 Feb 9.
2
Cerebral Cryptococcomas: A Systematic Scoping Review of Available Evidence to Facilitate Diagnosis and Treatment.脑隐球菌瘤:促进诊断与治疗的现有证据的系统综述
Pathogens. 2022 Feb 3;11(2):205. doi: 10.3390/pathogens11020205.
3
Cryptococcosis in Patients following Kidney Transplantation: A 9-Year Retrospective Clinical Analysis at a Chinese Tertiary Hospital.

本文引用的文献

1
AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: emerging management problems.高效抗逆转录病毒治疗时代前后的艾滋病相关隐球菌感染:新出现的管理问题
Int J Antimicrob Agents. 2003 Oct;22(4):449-52. doi: 10.1016/s0924-8579(03)00113-4.
2
The lipid formulations of amphotericin B.两性霉素B的脂质制剂
Expert Opin Pharmacother. 2003 Aug;4(8):1277-87. doi: 10.1517/14656566.4.8.1277.
3
Voriconazole.伏立康唑
肾移植术后患者隐球菌病:中国一家三级医院 9 年回顾性临床分析。
Biomed Res Int. 2019 Nov 11;2019:7165160. doi: 10.1155/2019/7165160. eCollection 2019.
4
Influence of Experimental Cryptococcal Meningitis in Wistar Rats on Voriconazole Brain Penetration Assessed by Microdialysis.通过微透析评估实验性隐球菌性脑膜炎对Wistar大鼠伏立康唑脑穿透性的影响。
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00321-17. Print 2017 Jul.
5
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.胸腔积液作为播散性隐球菌病和真菌血症的初始临床表现:一种不寻常的表现及文献综述
BMC Infect Dis. 2015 Sep 22;15:385. doi: 10.1186/s12879-015-1132-4.
6
Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus.一名乌干达艾滋病患者的中枢神经系统隐球菌瘤
Med Mycol Case Rep. 2014 Aug 11;6:10-3. doi: 10.1016/j.mmcr.2014.08.003. eCollection 2014 Oct.
7
Diagnosis and Management of Cryptococcal Relapse.隐球菌复发的诊断与管理
J AIDS Clin Res. 2013 Apr 29;Suppl 3(3). doi: 10.4172/2155-6113.s3-003.
8
The antimicrobial activity of lapachol and its thiosemicarbazone and semicarbazone derivatives.拉帕醌及其硫代缩氨基脲和缩氨基脲衍生物的抗菌活性。
Mem Inst Oswaldo Cruz. 2013 May;108(3):342-51. doi: 10.1590/S0074-02762013000300013.
9
New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.新型隐球菌性脑膜炎的预防、诊断和治疗新视角。
Curr HIV/AIDS Rep. 2012 Sep;9(3):267-77. doi: 10.1007/s11904-012-0127-7.
10
Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis.76 例原发性肺隐球菌病免疫功能正常患者的回顾性分析。
Lung. 2012 Jun;190(3):339-46. doi: 10.1007/s00408-011-9362-8. Epub 2012 Jan 14.
Clin Ther. 2003 May;25(5):1321-81. doi: 10.1016/s0149-2918(03)80126-1.
4
Longitudinal study of cryptococcosis in adult solid-organ transplant recipients.成年实体器官移植受者隐球菌病的纵向研究。
Transpl Int. 2003 May;16(5):336-40. doi: 10.1007/s00147-002-0541-7. Epub 2003 Mar 4.
5
Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.接受高效抗逆转录病毒治疗的人类免疫缺陷病毒感染患者隐球菌性脑膜炎二级预防的停用:一项前瞻性、多中心、随机研究。
Clin Infect Dis. 2003 May 15;36(10):1329-31. doi: 10.1086/374849. Epub 2003 May 2.
6
Voriconazole: a new triazole antifungal agent.伏立康唑:一种新型三唑类抗真菌药物。
Ann Pharmacother. 2003 Mar;37(3):420-32. doi: 10.1345/aph.1C261.
7
Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients.隐球菌性脑膜炎:5521例连续器官移植受者的分析
Transpl Infect Dis. 2002 Dec;4(4):183-8. doi: 10.1034/j.1399-3062.2002.t01-1-02005.x.
8
Paradoxical intracranial cryptococcoma in a human immunodeficiency virus-infected man being treated with combination antiretroviral therapy.
Am J Med. 2002 Aug 1;113(2):155-7. doi: 10.1016/s0002-9343(02)01130-0.
9
Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.尽管一名艾滋病患者免疫功能已恢复,但仍因播散性隐球菌病导致髓内脓肿。
J Infect. 2002 Apr;44(3):185-8. doi: 10.1053/jinf.2001.0955.
10
The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review.艾滋病相关机会性感染的变化面貌:高效抗逆转录病毒治疗(HAART)时代的隐球菌病。病例报告与文献综述。
Mycopathologia. 1999 Nov;148(2):73-8. doi: 10.1023/a:1007156027134.